Terminal differentiation of spontaneous rheumatoid factor–secreting B cells from rheumatoid arthritis patients depends on endogenous interleukin‐1 0
Open Access
- 1 December 1995
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 38 (12) , 1771-1776
- https://doi.org/10.1002/art.1780381210
Abstract
Objective. The presence of serum rheumatoid factor (RF) and spontaneous RF-secreting B cells is a common feature in most patients with rheumatoid arthritis (RA). This study analyzed the cytokine(s) that controls the final maturation of B cells capable of spontaneous IgM-RF secretion in vitro. Methods. RA patients' peripheral blood mononuclear cells (PBMC), as well as adherent and nonadherent cell fractions, were cultured, and spontaneous IgM-RF and interleukin-1 0 (IL-1 0) secretion were determined by enzyme-linked immunosorbent assay. Results. The RF+ RA PBMC, but not PBMC from RF– RA patients or healthy controls, actively produced IgM-RF in a linear manner for 14 days. This activity depended on the presence of fetal calf serum and did not require cellular DNA synthesis. Spontaneous IgM-RF secretion depended on IL-1 0, as deduced from the following findings: 1) IL-1 0, but not a variety of cytokines including IL-6, restored missing IgM-RF secretion by PBMC in serum-free supplemented cultures; 2) the addition of anti–IL-1 0, but not anti–IL-6, blocking antibodies inhibited PBMC IgM-RF secretion, and this effect could be reversed by exogenous IL-1 0; and 3) RA PBMC actively produced IL-1 0 in vitro. The cells responsible for endogenous IL-1 0 production were found in the adherent cell fraction. Finally, IL-1 0 induced IgM-RF, but not total IgM, secretion by RA PBMC. Conclusion. In patients with RA, circulating B cells capable of spontaneous IgM-RF secretion require IL-1 0 production by adherent cells to reach terminal maturation.Keywords
This publication has 27 references indexed in Scilit:
- Rheumatoid factor production by mononuclear cells derived from different sites of patients with rheumatoid arthritisClinical and Experimental Immunology, 1993
- IL-2 enhances polyclonal IgM but not IgM-rheumatoid factor synthesis by activated human peripheral blood B cellsClinical and Experimental Immunology, 1993
- LOCALIZATION OF INTERLEUKIN-1α, TYPE 1 INTERLEUKIN-1 RECEPTOR AND INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE SYNOVIAL MEMBRANE AND CARTILAGE/PANNUS JUNCTION IN RHEUMATOID ARTHRITISRheumatology, 1992
- Expression of granulocyte‐macrophage colony‐stimulating factor in rheumatoid arthritis: Regulation by tumor necrosis factor‐αEuropean Journal of Immunology, 1991
- Rheumatoid ArthritisNew England Journal of Medicine, 1990
- Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.Journal of Clinical Investigation, 1989
- Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serumArthritis & Rheumatism, 1988
- Enhanced in vitro synthesis of igm rheumatoid factor in rheumatoid arthritisArthritis & Rheumatism, 1980
- Rheumatoid factor: Its nature, specificity, and production in rheumatoid arthritisClinical Immunology and Immunopathology, 1976
- The Immunopathology of Joint Inflammation in Rheumatoid ArthritisPublished by Elsevier ,1973